天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester

Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester Struktur
1936127-34-2
CAS-Nr.
1936127-34-2
Englisch Name:
Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester
Synonyma:
tert-butyl 3-oxo-2,4-dihydropyrido[3,4-b]pyrazine-1-carboxylate;tert-butyl 3-oxo-3,4-dihydropyrido[3,4-b]pyrazine-1(2H)-carboxylate;Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester
CBNumber:
CB612237812
Summenformel:
C12H15N3O3
Molgewicht:
249.27
MOL-Datei:
1936127-34-2.mol

Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester Eigenschaften

Siedepunkt:
423.5±40.0 °C(Predicted)
Dichte
1.244±0.06 g/cm3(Predicted)
pka
12.23±0.20(Predicted)

Sicherheit

Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
sales1@artkmedchem.com China 39004 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
sales@pharmablock.com China 7268 58
Huanuo Pharmaceutical Technology (Guangxi) Co., Ltd 13005928603
211017228@qq.com China 6658 58

  • Pyrido[3,4-b]pyrazine-1(2H)-carboxylic acid, 3,4-dihydro-3-oxo-, 1,1-dimethylethyl ester
  • tert-butyl 3-oxo-2,4-dihydropyrido[3,4-b]pyrazine-1-carboxylate
  • tert-butyl 3-oxo-3,4-dihydropyrido[3,4-b]pyrazine-1(2H)-carboxylate
  • 1936127-34-2
Copyright 2019 ? ChemicalBook. All rights reserved